Kestra Advisory Services’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.52M Buy
178,538
+19,344
+12% +$397K 0.01% 1091
2026
Q2
$3.11M Buy
159,194
+6,987
+5% +$139K 0.01% 1101
2026
Q1
$2.93M Sell
152,207
-23,627
-13% -$465K 0.01% 1076
2025
Q4
$3.33M Buy
175,834
+183
+0.1% +$3.39K 0.01% 950
2025
Q3
$3.27M Buy
175,651
+37,112
+27% +$693K 0.02% 913
2025
Q2
$2.55M Sell
138,539
-3,578
-3% -$63.5K 0.01% 954
2025
Q1
$2.48M Sell
142,117
-11,073
-7% -$187K 0.01% 890
2024
Q4
$2.65M Buy
153,190
+88,635
+137% +$1.62M 0.01% 852
2024
Q3
$1.2M Sell
64,555
-13,606
-17% -$229K 0.01% 1222
2024
Q2
$1.2M Sell
78,161
-2,262
-3% -$32.3K 0.01% 1212
2024
Q1
$1.19M Buy
80,423
+57,452
+250% +$796K 0.01% 1140
2023
Q4
$328K Buy
+22,971
New +$326K ﹤0.01% 1789
2023
Q3
– Sell
-21,454
Closed -$253K – 2217
2023
Q2
$253K Buy
+21,454
New +$244K ﹤0.01% 1751

Other funds holding SBRA

Kestra Advisory Services's SBRA Position: Q3 2026 in Review

Kestra Advisory Services increased its Sabra Healthcare REIT (SBRA) stake by 12% in Q3 2026, buying an estimated $397K and bringing the position to 178,538 shares worth $3.52M. The position accounts for 0.01% of the portfolio, ranked #1091.

Kestra Advisory Services first reported a position in SBRA in Q2 2023 and has held it in 13 quarters since. 199 funds tracked by Wall St. Rank hold SBRA as of Q3 2026.

  • Kestra Advisory Services held 178,538 shares of Sabra Healthcare REIT worth $3.52M as of Q3 2026.
  • Kestra Advisory Services bought 19,344 Sabra Healthcare REIT shares in Q3 2026, an estimated $397K.
  • Sabra Healthcare REIT made up 0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #1091 holding.
  • Kestra Advisory Services first reported a position in Sabra Healthcare REIT in Q2 2023 and has held it in 13 quarters since.
  • 199 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2026.

Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.